Cystic fluid biomarkers for the differential diagnosis of inflammatory and non-inflammatory cystic pancreatic lesions (Neutrophil gelatinase-associated lipocalin (NGAL); Interleukin 1 Beta(IL 1β); High-mobility group AT-hook 2(HmgA2))
Miruna Patricia Olar(Iuliu Hațieganu University of Medicine and Pharmacy), Andrada Seicean(Iuliu Hațieganu University of Medicine and Pharmacy), A. H. Nadim(Iuliu Hațieganu University of Medicine and Pharmacy), Ofelia Moșteanu(Iuliu Hațieganu University of Medicine and Pharmacy), Ioana Rusu(Institutul Regional de Gastroenterologie Prof. Dr. Octavian Fodor), Cristina Pojoga(Babeș-Bolyai University), Radu Seicean(Iuliu Hațieganu University of Medicine and Pharmacy), Sorana D. Bolboacă(Iuliu Hațieganu University of Medicine and Pharmacy), Zeno Spârchez(Iuliu Hațieganu University of Medicine and Pharmacy), Maria Iacobescu(Iuliu Hațieganu University of Medicine and Pharmacy), Cristina Adela Iuga(Iuliu Hațieganu University of Medicine and Pharmacy)
Cited by 0
Related Papers
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
|New England Journal of Medicine|2022|264
Contrast-Enhanced Ultrasound (CEUS) For The Evaluation Of Focal Liver Lesions – A Prospective Multicenter Study Of Its Usefulness In Clinical Practice
|Ultraschall in der Medizin - European Journal of Ultrasound|2014|81
Are presepsin and resistin better markers for bacterial infection in patients with decompensated liver cirrhosis?
|Digestive and Liver Disease|2019|27
From Gut to Brain: Uncovering Potential Serum Biomarkers Connecting Inflammatory Bowel Diseases to Neurodegenerative Diseases
|International Journal of Molecular Sciences|2024|17